Shares of Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report) were down 3.8% on Tuesday . The stock traded as low as C$0.25 and last traded at C$0.26. Approximately 384,329 shares changed hands during trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Price Performance
The company has a 50 day moving average of C$0.26 and a two-hundred day moving average of C$0.26. The firm has a market cap of C$52.28 million and a P/E ratio of -0.37. The company has a quick ratio of 2.61, a current ratio of 2.97 and a debt-to-equity ratio of 35.45.
Emerald Health Therapeutics Company Profile
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015.
Featured Articles
- Five stocks we like better than Emerald Health Therapeutics
- What is the NASDAQ Stock Exchange?
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Stock Splits, Do They Really Impact Investors?
- What Does the Future Hold for Eli Lilly?
- What Do S&P 500 Stocks Tell Investors About the Market?
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
